Daewoong pharmaceutical

069620.KO

111.17 USD

-6.02

-5.14%

Overview

Last close

111.17 usd

Market cap

1.28B usd

52 week high

131.00 usd

52 week low

76.68 usd

Target price

146.35 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.2076

Price/Book Value

2.2271

Enterprise Value

1.75B usd

EV/Revenue

1.6501

EV/EBITDA

14.5538

Key financials

Revenue TTM

1.06B usd

Gross Profit TTM

550.24M usd

EBITDA TTM

164.78M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

1.61B usd

Net debt

418.75M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.